Evaluate the Prognostic Significance of Changes in the Systemic Immune-Inflammation Index in Patients with AGC Treated with ICI Therapy.
Clinical trial NCT06706466 · COMPLETED
Trial details
- NCT number
- NCT06706466
- Sponsor
- Chang-Ming Huang, Prof.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-01-01
- Primary completion
- 2021-12-31
- Enrollment
- 410
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.